CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Aryeh Jason Director | Sale | −500 | $319.99 | $160K | 107,976 |
| 2026-11-10 | Aryeh Jason Director | Sale | −844 | $320.00 | $270K | 107,132 |
| 2026-11-10 | Aryeh Jason Director | Sale | −646 | $320.00 | $207K | 106,486 |
| 2026-11-10 | Aryeh Jason Director | Sale | −10 | $320.02 | $3K | 106,476 |
| 2026-11-10 | Aryeh Jason Director | Sale | −500 | $320.10 | $160K | 105,976 |
| 2026-11-10 | Aryeh Jason Director | Sale | −500 | $320.20 | $160K | 105,476 |
| 2026-11-04 | Aryeh Jason Director | Sale | −282 | $319.99 | $90K | 108,476 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Option exercise 10b5-1 | +5,000 | $52.27 | $261K | 36,854 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −283 | $307.39 | $87K | 36,571 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −708 | $308.43 | $218K | 35,863 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −522 | $309.91 | $162K | 35,341 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −490 | $310.61 | $152K | 34,851 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −520 | $311.72 | $162K | 34,331 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −634 | $312.85 | $198K | 33,697 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −403 | $313.75 | $126K | 33,294 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −80 | $314.58 | $25K | 33,214 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −280 | $317.91 | $89K | 32,934 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −440 | $318.73 | $140K | 32,494 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −320 | $319.97 | $102K | 32,174 |
| 2026-11-02 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −200 | $321.44 | $64K | 31,974 |
Page 1 of 43 · 858 trades